INTRODUCTION
It is well verified that many transition metals-1,2 and rare earth metals-amino acids complexes 3 have considerable biological activity, such as antitumor properties. Ga(NO 3 ) 3 has exhibited clinical activity against lymphomas 4 and bladder carcinomas. 5, 6 Ruthenium complexes, such as ammine, amine, and heterocyclic complexes of ruthenium (III) exhibit inhibition of DNA replication. 7 Many Rh (II)-and other transition metal-complexes have shown good antitumor activities. 8 Transition metal complexes of thiourea derivatives of glycine, 9, 10 hisitidine, phenylalanine, serine, alanine and cysteine have been prepared and characterized.
11
A new series of amino acid esters bearing coumarin were synthesized and evaluated, in vitro, against HIV-1 and bovine viral diarrhea virus (BVDV). 12 J. David invented method producing hydroxyamino-acids, esters, or derivative, thereof , is provided 13 through regioselective or enzymatic hydrolysis followed by rearrangement for substituted β-ketodiester giving the final product. A convenient microwave assisted synthesis of N-glycosyl aminoacids, in which complying reaction of glycosylamines with Fmoc-protected aspartic acid, by microwave approach was described.
14 Recently a novel synthetic method for isomeric peptides through an appropriate linkage of L-selenomethionine or Se-Methyl-L-selenocysteine with L-glutamic acid producing peptides of L-Selenomethionine or Se-Methyl-L-selenocysteine which have among other properties ,capabilities to prevent, reduce hair fall and promote hair growth. 15 A series of antibacterial and antifungal amino acid-derived compounds and their Co(II)-, Cu(II)-, Ni(II)-, and Zn(II)-complexes; [M(L)(H2O)4]Cl have been synthesized and characterized by elemental analysis, molar conductance, magnetic moments, IR and electronic spectral measurements. The ligand (L) were derived by condensation of β-diketones with glycine, phenylalanine, valine and histidine. 16 Recently, a series of amino acid ester derivatives containing 5-fluorouracil were synthesized using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) and N-hydroxybenzotriazole (HOBt) as a coupling agent. 17 The in vitro antitumor activity tests against leukaemia HL-60 and liver cancer BEL-7402 indicated that (R)-ethyl 2-(2-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1-(2H-yl-acetamido)-3-(4-hydroxyphenyl) propanoate showed more inhibitory effect against BEL-7402 than 5-FU. 17 A new non-natural arginine-like amino acid derivative with a sulfamoyl group in the side-chain were synthesized by Sulfamoylation of the L-ornithine methyl ester side-chain generates a non-natural arginine isostere. 
Physical Measurements
The IR -spectra were recorded on Shimadzu FTIR -8400 spectrometer using KBr pellets in the range 4000 -400 cm -1 . Elemental analysis were performed on EA 3000 A-Eurovector. 1 H NMR-spectra were recorded on Bruker Ultra shield 300 MHz using tetraflouroacetic acid and MeOD as solvents and TMS as internal standard.
Synthesis of the ligands (HL)
(i) Preparation of the benzoylisothiocyante was done as described in the literature. 11 Equivalent molal ratios of benzoyl chloride and ammonium thiocyanate in acetone was refluxed for 1hr.,and worked up as the literature method to give pure filtrate.
11
(ii) preparation of N-[(benzoyl amino)thioxomethyl]-aspartic acid (BATA) (1) was carried out by applying the general procedure as in the literature, 11 by adding rapidly (0.01 mmol)
of aspartic acid to the above solution in (i) to maintain vigorous reflux for 6 h. The resultant solid product was collected, washed with acetone and recrystallized using column chromatography with eluent (ethanol : chloroform = 4 : 1) giving a white solid. Yield (65%). m.p. = 273 -275 o C. Similarly, the glutamic acid-, leucine-, and tryptophanderivatives; i.e compounds 2-5 were obtained applying similar procedure as in (ii) above. Physical properties for compounds 1-5 are given in Table 1 .
Synthesis of the metal complex compounds (6-8) 11
1.24 mmol of the ligand (HL) was dissolved in 25 mL of pure methanol containing 1.24 mmol of NaOH. A solution of metal chloride; (0.62 mmol); MCl2{M:Co(II),Cu(II) or Ni(II)}, in methanol was added dropwise over the ligand (HL) basic solution, and the precipitate appeared immediately. After stirring the mixture at room temperature for 2 h, the precipitate was collected by filtration, washed with methanol and dried under vacuum. Further purification applying column chromatography (methanol / chloroform = 4.5 : 0.5) gave the purest solid products with melting points shown in Table 1 .
RESULTS AND DISCUSSION

Synthesis of the ligands
The synthesis of the ligands 1-5 requires firstly the preparation of benzoylisothiocyante, 9 and subsequent reactions with respective amino acid (HL) under reflux in acetone, as shown in Scheme 1.
Infrared spectra
The IR spectra for the ligands 1-5 shows similarity in some absorption frequencies: aromatic C-H stretching in the range 3000 -3100 cm Table 3 . (5)] bands except the disappearance of carboxylic proton at 11.045 ppm which also indicates the coordination via carboxylate oxygen atoms to the metal ion. Details of 1 H NMR spectra for the ligands 1-5 and complexes 6-8 are given in Figs. 1-8 and Table 3 .
In accordance with the elemental analysis, IR and NMR spectra data, we suggest that the structure of the ligands 1-5 shown below, resembling the general formula which was also 
HL
Biological activity
Antibacterial activity: By using agar diffusion technique, 21, 22 the ligands antibacterial activities have been studied in vitro against Escherichia coli (NCTC 5933) and Staphylococcus aureus (NCTC 6571). All five ligands 1-5 have no effect upon these two types of bacteria ,whereas all the complexes 6-8 show antibacterial activities for both types. The results of bacterial growth inhibition data are given in Table 5 .
Medium Lethal Dose [LD50]:
Twenty one white female Albino mice had been used for this study. They were divided into seven groups. One group (6 mice) was the control group which were given orally distilled water , whereas the other groups had been given orally (200, 400, 600, 800 and 1000) mg/kg doses of the complexes;[Cu(BATA)2] (6), [Co (BATM) 2 ] (7), and [Ni(BATM) 2 ] (8). No toxicity effect for these complexes 6-8 has been observed after 72 h for all groups of mice; i.e. no lethal cases.
All the ligands 1-5 show no antibacterial activity, whereas the metal complexes of these ligands 6-8 have antibacterial activities. Besides, all these complex compounds 6-8 have no toxicity toward mice, hence they may replace cisplatin compounds as anticancer drugs which have toxic side effect for human being. To confirm such idea it needs further future study to be regarded as an invention if possible as anticancer drug.
